Some characteristics of two azoreductase systems in rat liver. Relevance to the activity of 2-[4'-di(2″-bromopropyl)-aminophenylazo]benzoic acid (CB10-252), a compound possessing latent cytotoxic activity

This publication has 21 references indexed in Scilit:

• The effects of the continuous administration of N,N-dimethyl-4-phenylazoaniline (DAB) on the activities and the inducibilities of some drug-metabolizing enzymes in rat liver
  Chemico-Biological Interactions, 1975
• Activation by reductive cleavage of potentially cytotoxic azo compounds by human hepatocellular carcinoma
  Biochemical Pharmacology, 1974
• Cytotoxic Agents Designed To Be Selective for Liver Cancer2
  JNCI Journal of the National Cancer Institute, 1973
• The effect of the administration of n,n-dimethyl-4-aminoazobenzene (dab) on the activity of dab-reductase and nadph-cytochrome c reductase
  Chemico-Biological Interactions, 1970
• Studies on the mechanism of action of mammalian hepatic azoreductase—II
  Biochemical Pharmacology, 1967
• Studies on the mechanism of action of mammalian hepatic azoreductase—I
  Biochemical Pharmacology, 1967
• Relative Rates of Reduction of a Series of Azo Compounds
  Journal of the Society of Dyers and Colourists, 1959
• 276. Aryl-2-halogenoalkylamines. Part XVI. The preparation of derivatives of 4-[di-(2-chloroalkyl)amino]azobenzenes
  Journal of the Chemical Society, 1956
• 337. Aryl-2-halogenoalkylamines. Part XVII. The ultraviolet absorption spectra of some 4-di-(2-chloroethyl)aminoazobenzenes in neutral and acidic ethanol solutions
  Journal of the Chemical Society, 1956
• Reduction of Cytotoxic Azo Compounds by Hydrazine and by the Xanthine Oxidase–Xanthine System
  Nature, 1955